Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amrep (AXR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Amrep (AXR) over the last 16 years, with Q4 2025 value amounting to $45.1 million.

  • Amrep's Cash & Equivalents rose 1103.7% to $45.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $45.1 million, marking a year-over-year increase of 1103.7%. This contributed to the annual value of $39.9 million for FY2025, which is 3200.95% up from last year.
  • As of Q4 2025, Amrep's Cash & Equivalents stood at $45.1 million, which was up 1103.7% from $49.4 million recorded in Q3 2025.
  • In the past 5 years, Amrep's Cash & Equivalents ranged from a high of $49.4 million in Q3 2025 and a low of $12.4 million during Q1 2023
  • Moreover, its 5-year median value for Cash & Equivalents was $24.0 million (2021), whereas its average is $26.9 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 5750.32% in 2022, then soared by 14296.99% in 2024.
  • Amrep's Cash & Equivalents (Quarter) stood at $30.3 million in 2021, then plummeted by 57.5% to $12.9 million in 2022, then rose by 29.74% to $16.7 million in 2023, then soared by 142.97% to $40.6 million in 2024, then grew by 11.04% to $45.1 million in 2025.
  • Its Cash & Equivalents stands at $45.1 million for Q4 2025, versus $49.4 million for Q3 2025 and $39.9 million for Q2 2025.